Cargando…

Biannual Treatment of Preschool Children with Single Dose Azithromycin to Reduce Mortality: Impact on Azithromycin Resistance in the MORDOR Trial in Tanzania

The Macrolides Oraux pour Réduire les Décès avec un Oeil sur la Résistance study showed that administration of biannual, single-dose azithromycin to preschool children reduces mortality. We sought to evaluate its impact on azithromycin resistance. Thirty randomly selected communities in Kilosa distr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bloch, Evan M., Coles, Christian L., Kasubi, Mabula, Weaver, Jerusha, Mrango, Zakayo, Munoz, Beatriz, Lietman, Thomas M., West, Sheila K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7470586/ https://www.ncbi.nlm.nih.gov/pubmed/32067633 http://dx.doi.org/10.4269/ajtmh.19-0086

Ejemplares similares

Impact of Biannual Azithromycin on Anemia in Preschool Children in Kilosa District, Tanzania: A Cluster-Randomized Clinical Trial
por: Bloch, Evan M., et al.
Publicado: (2020)

Causes of death after biannual azithromycin treatment: A community-level randomized clinical trial
por: Bloch, Evan M., et al.
Publicado: (2021)

The impact on malaria of biannual treatment with azithromycin in children age less than 5 years: a prospective study
por: Bloch, Evan M., et al.
Publicado: (2019)

Effect Modification by Baseline Mortality in the MORDOR Azithromycin Trial
por: Oron, Assaf P., et al.
Publicado: (2020)

Mass Oral Azithromycin for Childhood Mortality: Timing of Death After Distribution in the MORDOR Trial
por: Porco, Travis C, et al.
Publicado: (2019)

Biannual azithromycin distribution and child mortality among malnourished children: A subgroup analysis of the MORDOR cluster-randomized trial in Niger
por: O’Brien, Kieran S., et al.
Publicado: (2020)

MORDOR II: Persistence of Benefit of Azithromycin for Childhood Mortality
por: Keenan, Jeremy D., et al.
Publicado: (2019)

The Babesia observational antibody (BAOBAB) study: A cross-sectional evaluation of Babesia in two communities in Kilosa district, Tanzania
por: Bloch, Evan M., et al.
Publicado: (2019)

Effect of Mass Treatment with Azithromycin on Causes of Death in Children in Malawi: Secondary Analysis from the MORDOR Trial
por: Hart, John D., et al.
Publicado: (2020)

Evaluation of a Single Dose of Azithromycin for Trachoma in Low-Prevalence Communities
por: Wilson, Nana, et al.
Publicado: (2018)

Cost-Effectiveness of Mass Treatment with Azithromycin for Reducing Child Mortality in Malawi: Secondary Analysis from the MORDOR Trial
por: Hart, John D., et al.
Publicado: (2020)

Effect of Biannual Mass Azithromycin Distributions to Preschool-Aged Children on Trachoma Prevalence in Niger: A Cluster Randomized Clinical Trial
por: Arzika, Ahmed M., et al.
Publicado: (2022)

Mass azithromycin distribution for reducing childhood mortality in sub-Saharan Africa
por: Keenan, Jeremy D, et al.
Publicado: (2018)

Biannual versus annual mass azithromycin distribution and malaria seroepidemiology among preschool children in Niger: a sub-study of a cluster randomized trial
por: Oldenburg, Catherine E., et al.
Publicado: (2019)

Efficacy of Mass Azithromycin Distribution for Reducing Childhood Mortality Across Geographic Regions
por: Porco, Travis C., et al.
Publicado: (2020)

Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger
por: Arzika, Ahmed M., et al.
Publicado: (2022)

Impact of Biannual Mass Azithromycin Treatment on Enteropathogen Carriage in Children <5 Years Old in Niger
por: Platts-Mills, James A, et al.
Publicado: (2022)

Effects of Biannual Azithromycin Mass Drug Administration on Malaria in Malawian Children: A Cluster-Randomized Trial
por: Hart, John D., et al.
Publicado: (2020)

Biannual mass azithromycin distributions and malaria parasitemia in pre-school children in Niger: A cluster-randomized, placebo-controlled trial
por: Arzika, Ahmed M., et al.
Publicado: (2019)

Mass Azithromycin Distribution to Prevent Childhood Mortality: A Pooled Analysis of Cluster-Randomized Trials
por: Oldenburg, Catherine E., et al.
Publicado: (2019)

Can We Use Antibodies to Chlamydia trachomatis as a Surveillance Tool for National Trachoma Control Programs? Results from a District Survey
por: West, Sheila K., et al.
Publicado: (2016)

Number of Years of Annual Mass Treatment With Azithromycin Needed to Control Trachoma in Hyper-endemic Communities in Tanzania
por: West, Sheila K., et al.
Publicado: (2011)

Age-based targeting of biannual azithromycin distribution for child survival in Niger: an adaptive cluster-randomized trial protocol (AVENIR)
por: O’Brien, Kieran S., et al.
Publicado: (2021)

A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma
por: West, Sheila K., et al.
Publicado: (2013)

Cause-specific mortality of children younger than 5 years in communities receiving biannual mass azithromycin treatment in Niger: verbal autopsy results from a cluster-randomised controlled trial
por: Keenan, Jeremy D, et al.
Publicado: (2020)

Short-Term Malaria Reduction by Single-Dose Azithromycin during Mass Drug Administration for Trachoma, Tanzania
por: Schachterle, Stephen E., et al.
Publicado: (2014)

The efficacy of oral azithromycin in clearing ocular chlamydia: Mathematical modeling from a community-randomized trachoma trial
por: Liu, Fengchen, et al.
Publicado: (2014)

Trachomatous Scarring and Infection With Non–Chlamydia Trachomatis Bacteria in Women in Kongwa, Tanzania
por: Cox, Jacob T., et al.
Publicado: (2017)

Biannual Administrations of Azithromycin and the Gastrointestinal Microbiome of Malawian Children: A Nested Cohort Study Within a Randomized Controlled Trial
por: Chaima, David, et al.
Publicado: (2022)

Effect of Biannual Azithromycin to Children under 5 Years on the Carriage of Respiratory Pathogens among Children Aged 7–11 Years
por: Brennhofer, Stephanie A., et al.
Publicado: (2023)

Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households
por: Ssemanda, Elizabeth N., et al.
Publicado: (2010)

Linear growth in preschool children treated with mass azithromycin distributions for trachoma: A cluster-randomized trial
por: Keenan, Jeremy D., et al.
Publicado: (2019)

Azithromycin Mass Treatment for Trachoma Control: Risk Factors for Non-Participation of Children in Two Treatment Rounds
por: Ssemanda, Elizabeth N., et al.
Publicado: (2012)

Optimal Seasonal Timing of Oral Azithromycin for Malaria
por: Gao, Daozhou, et al.
Publicado: (2014)

Reduction of Coronavirus Burden With Mass Azithromycin Distribution
por: Doan, Thuy, et al.
Publicado: (2020)

Macrolide Resistance in MORDOR I: A Cluster-Randomized Trial in Niger
por: Doan, Thuy, et al.
Publicado: (2019)

Azithromycin (Zithromax(®))
por: McCarty, James M.
Publicado: (1996)

Azithromycin for Malaria?
por: Rosenthal, Philip J.
Publicado: (2016)

Gut Resistome of Preschool Children After Prolonged Mass Azithromycin Distribution: A Cluster-randomized Trial
por: Arzika, Ahmed M, et al.
Publicado: (2021)

Serology, infection, and clinical trachoma as tools in prevalence surveys for re-emergence of trachoma in a formerly hyperendemic district
por: Odonkor, Michelle, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f78kuj05fbbdj7892rkucb0o9v